Page 31 - Small Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

©Elmin Media . All Rights Reserved. MDMA-Assisted Psychotherapy: Awakn, led by Anthony Tennyson, George Scorsis, Dr. Ben Sessa, moves forward with Phase II Study Tuesday, February 9, 2021 1:54 AM UTC Researchers behind United Kingdom-based Awakn Life Sciences Inc. believe that the use of psychedelics combined with psychotherapy is the next evolution in psychiatric treatment. They are now one step closer to achieving their mission to incorporate these methods into mainstream care in the UK and European Union. According to a ...

Cannabis Mergers and Acquisitions Are Heating Up, With More Than $600 Million in Deals Announced Last Tuesday Alone and That’s on Top of Additional Transactions Unveiled Since the 2020 U.S. Election Last Month New York-based Multi-State Operator (MSO) Columbia Care (CSE:CCHW) (OTCQX:CCHWF) (FSE: 3LP) announced Tuesday it reached a deal to acquire privately-held Green Leaf Medical for $240 million, expanding its presence in the Mid-Atlantic. Ayr Strategies (CSE:AYR) (OTCQX:AYRSF), of New York and Toronto, announced a $290 million all-stock acquisition of Florida-based Liberty Health (...

NationofChange UK regulators give okay to use psychedelic drug to treat depression in first clinical trial "We think this could be a treatment for a number of depressive disorders besides major depression, including PTSD, treatment-resistant depression, obsessive-compulsive disorder, and possibly some types of substance abuse." Dimethyltriptamine, a psychedelic drug, will soon be trial-led in the United Kingdom to treat depression. UK Regulators will begin the trial by giving the “spirit molecule” drug to healthy individuals and then follow it up with a second trial on patient...

Compared to psilocybin, DMT trips are shorter in duration, but more intense. “Whereas a psilocybin session takes all day — and if you’re doing two or even more of those, that’s a large time commitment — a DMT session, all in, will probably take under two hours,” Peter Rands, Small Pharma’s CEO, told The Guardian. “We expect DMT to be rapid-acting, equivalent or perhaps even better than psilocybin, so within hours of a session, you will get rapid relief [from your depression]. We also expect the effect to be sustained over a similar time period,” R...

Canada Allows Professionals In Training To Use Psilocybin The decision, announced Tuesday, marks the latest step in Canada’s path towards the legalization of psilocybin. Since August 2020, Canada’s Health Minister has granted 14 exemptions to access psilocybin therapy, mainly for patients dealing with end-of-life distress. “Health Canada now rightfully acknowledges that clinician experience with psychedelic medicines is an important part of their training. Therapists having psychedelic experience are able to more deeply empathize with patients and understand their experience,” said Br...